Antiviral combination based on dihydropyrimidine derivatives and non-dihydropyrimidine HBV antiviral agents, are useful for treatment of HBV infections

摘要

A synergistic combination comprising dihydropyrimidines and HBV antiviral agents other than dihydropyrimidines, is new. A synergistic combination comprises: (A) at least one dihydropyrimidine; (B) at least one HBV antiviral agent other than (A); and optionally (C) at least one immunomodulator. An Independent claim is also included for a combination of HBV core protein inhibitor(s), HBV antiviral agent(s) other than HBV core protein inhibitors and optionally immunomodulator(s).